0000950170-23-051939.txt : 20231004
0000950170-23-051939.hdr.sgml : 20231004
20231004164553
ACCESSION NUMBER: 0000950170-23-051939
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231002
FILED AS OF DATE: 20231004
DATE AS OF CHANGE: 20231004
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Werner Jason M.
CENTRAL INDEX KEY: 0001977446
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34703
FILM NUMBER: 231308605
MAIL ADDRESS:
STREET 1: 6310 TOWN SQUARE
STREET 2: SUITE 400
CITY: ALPHARETTA
STATE: GA
ZIP: 30005
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALIMERA SCIENCES INC
CENTRAL INDEX KEY: 0001267602
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 200028718
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6310 TOWN SQUARE
STREET 2: SUITE 400
CITY: ALPHARETTA
STATE: GA
ZIP: 30005
BUSINESS PHONE: 678-990-5740
MAIL ADDRESS:
STREET 1: 6310 TOWN SQUARE
STREET 2: SUITE 400
CITY: ALPHARETTA
STATE: GA
ZIP: 30005
4
1
ownership.xml
4
X0508
4
2023-10-02
0001267602
ALIMERA SCIENCES INC
ALIM
0001977446
Werner Jason M.
6310 TOWN SQUARE
SUITE 400
ALPHARETTA
GA
30005
false
true
false
false
Chief Operating Officer
false
Common Stock
2023-10-02
4
A
false
225000
0.00
A
225000
D
Stock Option (Right to Buy)
2.99
2023-10-02
4
A
false
225000
0
A
2033-10-01
Common Stock
225000
225000
D
Represents shares of common stock underlying a time-based restricted stock unit award (RSU). The RSUs vest in four equal annual installments beginning October 2, 2023, with the first annual installment vesting on October 2, 2024, so long as the Reporting Person's service as an employee of the Issuer is continuous from the grant date through the applicable anniversary thereof.
The options shall vest and become exercisable with respect to twenty-five percent (25%) of the shares after twelve (12) months of the Reporting Person's continuous service commencing on October 2, 2023, and the balance will vest in equal monthly installments over the next thirty-six (36) months of the Reporting Person's continuous service with the Issuer thereafter, with the final installment adjusted as necessary to avoid any fractional shares in any installment.
/s/ Jason Werner
2023-10-04